financetom
Business
financetom
/
Business
/
Public Service Enterprise Group Q2 Adjusted Earnings, Revenue Rise; 2025 Guidance Maintained
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Public Service Enterprise Group Q2 Adjusted Earnings, Revenue Rise; 2025 Guidance Maintained
Aug 5, 2025 5:28 AM

07:57 AM EDT, 08/05/2025 (MT Newswires) -- Public Service Enterprise Group ( PEG ) reported Q2 adjusted earnings Tuesday of $0.77 per share, up from $0.63 a year earlier.

Analysts surveyed by FactSet expected $0.70.

Revenue for the quarter ended June 30 was $2.81 billion, up from $2.42 billion a year earlier.

Analysts polled by FactSet expected $2.38 billion.

The company maintained its 2025 non-GAAP operating earnings guidance of $3.94 to $4.06 per share. Analysts surveyed by FactSet expect $4.01.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Progressive Keeps Quarterly Dividend at $0.10 per Share, Payable April 11 to Shareholders of Record as of April 3
--Progressive Keeps Quarterly Dividend at $0.10 per Share, Payable April 11 to Shareholders of Record as of April 3
Mar 10, 2025
10:29 AM EDT, 03/10/2025 (MT Newswires) -- Price: 282.68, Change: +2.86, Percent Change: +1.02 ...
Enstar Launches $350 Million Tender Offer
Enstar Launches $350 Million Tender Offer
Mar 10, 2025
10:26 AM EDT, 03/10/2025 (MT Newswires) -- Enstar Group ( ESGR ) said Monday it started a cash tender offer for any and all of the $350 million outstanding 5.75% fixed-rate reset junior subordinated notes due 2040 issued by its unit, Enstar Finance. Enstar ( ESGR ) will pay $1,000 for an equal principal amount of notes validly tendered and...
Emergent to Sell Baltimore-Bayview Facility for $36.5 Million
Emergent to Sell Baltimore-Bayview Facility for $36.5 Million
Mar 10, 2025
10:27 AM EDT, 03/10/2025 (MT Newswires) -- Emergent BioSolutions ( EBS ) said Monday it has agreed to sell its Baltimore-Bayview drug substance manufacturing facility to Syngene International for $36.5 million. The facility includes manufacturing, laboratory, warehouse, and office space, the company said. It expects to close the sale in Q1. Emergent will retain the rights to secure manufacturing services...
Novo Nordisk Shares Decline as New Trial Data on Weight Loss Drug Miss Expectations
Novo Nordisk Shares Decline as New Trial Data on Weight Loss Drug Miss Expectations
Mar 10, 2025
10:29 AM EDT, 03/10/2025 (MT Newswires) -- Novo Nordisk's ( NVO ) US-listed stock was falling intraday Monday after the latest trial results of the Danish pharmaceutical giant's investigative weight loss drug trailed its own initial expectations. Patients treated with the therapeutic candidate, called CagriSema, experienced a weight loss of 15.7% after 68 weeks versus 3.1% with placebo, based on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved